Keeley M. Cain Wettan - 10 Mar 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP Gen Counsel, Legal & Comp
Signature
/s/ Amy Kim by Power of Attorney for Keeley M. Cain Wettan
Issuer symbol
GILD
Transactions as of
10 Mar 2026
Net transactions value
$0
Form type
4
Filing time
12 Mar 2026, 16:39:59 UTC
Previous filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp 333 LAKESIDE DRIVE, FOSTER CITY /s/ Amy Kim by Power of Attorney for Keeley M. Cain Wettan 12 Mar 2026 0002110603

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +1,246 +28% 5,660 10 Mar 2026 Direct F1
transaction GILD Common Stock Tax liability -606 -11% $148.56* 5,054 10 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -1,246 -7.4% 15,536 10 Mar 2026 Common Stock 1,246 Direct F1, F2
transaction GILD Restricted Stock Unit Award +5,050 +33% 20,586 10 Mar 2026 Common Stock 5,050 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award +18,885 $0.000000* 18,885 10 Mar 2026 Common Stock 18,885 $148.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The stock options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.